Medical Information
Dr. Said Daneshmand is an internationally recognized fertility expert with extensive experience in providing third-party reproductive services.
Dr. Daneshmand serves on the board of directors of multiple third-party fertility advocacy groups. Including PTEC (Extended Culture after Thawing), one of the most successful IVF protocols currently available. These groundbreaking findings were published in internationally renowned medical journals
Dr. Daneshmand also serves as a reviewer of Fertility and Sterility.
Dr. Daneshmand completed his scholarship and residency training at UCLA. He is certified by the Professional Committee of Obstetrics and Gynecology and the Subprofessional Committee of Reproductive Endocrinology.
Among his achievements, Dr. Daneshmand has received numerous awards, including the Irene Parker School of Medicine Farewell Speech Award and the PCRS Scholarship and Practitioner Research Award.
Among
his achievements, Dr. Daneshmand has received numerous awards, including the Irene Parker School of Medicine Farewell Speech Award and the PCRS Scholarship and Practitioner Research Award. He has served as chairman of the Alpha Omega Alpha Honorary Society (Iota Chapter) and is a member of the Decherney Society, American
Member of the Society for Reproductive Medicine (ASRM) and the European Society of Human Reproduction and Embryology (ESHRE). Dr. Daneshmand speaks French, Spanish and Persian.
nPersonal achievements
Dr. Daneshmand has expertise in complex IVF cases, and his research features endometrial receptivity to maximize the likelihood of IVF success. He is internationally renowned for his expertise in egg donation and third-party fertility assistance, and is a third-party nurse in the United States.
One of the major providers of treatment, with patients from more than 40 countries/regions in 2018 alone. Dr. Daneshmand has demonstrated his research around the world, including giving numerous lectures to China's leading IVF experts. He is known for developing and implementing cutting-edge technologies, including NGS
(Next Generation Sequencing) is the latest and most accurate technology for assessing the genetic health of embryos.
